Olympus Corp
OLY1
Company Profile
Business description
Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
Contact
Shinjuku Monolith
2-3-1 Nishi-Shinjuku
Shinjuku-ku
Tokyo163-0914
JPNT: +81 333402111
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2025
Employees
29,780
Stocks News & Analysis
stocks
Investors overly negative on undervalued ASX share
Road to profitability is in sight as management continues to take the right steps.
stocks
Reporting season preview: February 2025
As of Wednesday, 24 companies under coverage have reported; you’ll find our analysis throughout this issue.
stocks
Signs of a turnaround for undervalued ASX share
Market likes the payoff from early efforts at reining in costs.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,811.90 | 13.20 | -0.15% |
CAC 40 | 8,186.38 | 7.84 | 0.10% |
DAX 40 | 22,715.25 | 201.83 | 0.90% |
Dow JONES (US) | 44,546.08 | 165.35 | -0.37% |
FTSE 100 | 8,753.25 | 20.79 | 0.24% |
HKSE | 22,616.23 | 4.10 | -0.02% |
NASDAQ | 20,026.77 | 81.13 | 0.41% |
Nikkei 225 | 39,174.25 | 24.82 | 0.06% |
NZX 50 Index | 13,068.93 | 79.75 | 0.61% |
S&P 500 | 6,114.63 | 0.44 | -0.01% |
S&P/ASX 200 | 8,537.10 | 18.70 | -0.22% |
SSE Composite Index | 3,355.83 | 9.11 | 0.27% |